
无数据
无数据
无数据
| CAS Number | 51-21-8 |
| Catalog Number | AG003MRU(AGN-PC-0WABFT) |
| Chemical Name | 5-fluoro-1,2,3,4-tetrahydropyrimidine-2,4-dione |
| EC Number | 200-085-6 |
| IUPAC Name | 5-fluoro-1H-pyrimidine-2,4-dione |
| InChI | InChI=1S/C4H3FN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9) |
| InChI Key | GHASVSINZRGABV-UHFFFAOYSA-N |
| MDL Number | MFCD00006018 |
| Molecular Formula | C4H3FN2O2 |
| Molecular Weight | 130.0772 |
| SMILES | FC=1C(NC(NC1)=O)=O |
| UNII | U3P01618RT |
| Synonyms | 5 Fluorouracil,
5 Fluorouracil biosyn,
5 FU Lederle,
5 FU medac,
5 HU Hexal,
5-Fluorouracil,
5-Fluorouracil-biosyn,
5-FU,
5-FU Lederle,
5-FU medac,
5-HU Hexal,
5FU,
Adrucil,
Carac,
Dakota, Fluorouracile,
Efudex,
Efudix,
Fluoro Uracile ICN,
Fluoro-Uracile ICN,
Fluoroplex,
Fluorouracil,
Fluorouracil GRY,
Fluorouracil Mononitrate,
Fluorouracil Monopotassium Salt,
Fluorouracil Monosodium Salt,
Fluorouracil Potassium Salt,
Fluorouracil-GRY,
Fluorouracile Dakota,
Fluorouracilo Ferrer Far,
Fluoruracil,
Fluracedyl,
Flurodex,
Haemato fu,
Haemato-fu,
Neofluor,
Onkofluor,
Ribofluor,
5-Fluorouracil,
fluorouracil,
51-21-8,
5-FU,
Fluoroplex,
Adrucil,
Efudex,
Carac,
Fluracil,
Fluoroblastin,
5-fluoropyrimidine-2,4(1H,3H)-dione,
Kecimeton,
Carzonal,
Timazin,
Arumel,
Efudix,
Fluril,
5-Fluoracil,
Fluracilum,
Queroplex,
Ulup,
Phthoruracil,
Fluro Uracil,
5-Fluoro-2,4(1H,3H)-pyrimidinedione,
Fluorouracilum,
Ftoruracil,
Efurix,
Fluri,
5 Fluorouracil,
Effluderm (free base),
5-fluoro-1H-pyrimidine-2,4-dione,
Fluorouracilo,
Fluroblastin,
Phtoruracil,
2,4(1H,3H)-Pyrimidinedione, 5-fluoro-,
2,4-Dihydroxy-5-fluoropyrimidine,
Fluoro-uracile,
Fluoro-uracilo,
5-Fluoropyrimidine-2,4-dione,
Uracil, 5-fluoro-,
5-Fluoruracil,
5-Faracil,
Cinco FU,
Effluderm,
Ro 2-9757,
5-Fluor-2,4-pyrimidindiol,
Fluorouracile [DCIT],
5-Fluoracil [German],
5-fluoro uracil,
5-Ftouracyl,
5-Fluoruracil [German],
Fluorouracil, 5-,
Fluorouracilum [INN-Latin],
Fluorouracilo [INN-Spanish],
5-Fluoropyrimidin-2,4-diol,
5-fluoropyrimidine-2,4-diol,
NSC 19893,
2,4-Dioxo-5-fluoropyrimidine,
5-Fluoro-2,4-pyrimidinedione,
Fluorouracil (Adrucil),
5-Fluor-2,4-dihydroxypyrimidin,
U-8953,
5-fluoro-uracil,
FU,
5-Fluor-2,4-pyrimidindiol [Czech],
NSC-19893,
C4H3FN2O2,
UNII-U3P01618RT,
CCRIS 2582,
5-Fluor-2,4-dihydroxypyrimidin [Czech],
HSDB 3228,
5-Fluor-2,4(1H,3H)-pyrimidindion [Czech],
5-Fluorouracil, 99%,
EINECS 200-085-6,
MFCD00006018,
CHEMBL185,
Ro-2-9757,
5-fluoro-1,2,3,4-tetrahydropyrimidine-2,4-dione,
5-fluoro-2,4-Pyrimidinediol,
AI3-25297,
MLS000069498,
5FU,
CHEBI:46345,
GHASVSINZRGABV-UHFFFAOYSA-N,
U3P01618RT,
NSC19893,
Fluorouracil (5-Fluoracil, 5-FU),
191047-65-1,
URF,
NCGC00015442-02,
Fluorouracile,
SMR000038082,
DSSTox_CID_634,
5-Fluoracyl,
DSSTox_RID_75705,
DSSTox_GSID_20634,
Fluorouracil Cream,
CAS-51-21-8,
Fluoroplex (TN),
Adrucil (TN),
5-fluoro-1,3-dihydropyrimidine-2,4-dione,
Carac (TN),
SR-01000075881,
Fluorouracil [USAN:INN:BAN:JAN],
5-Fluor-2,4(1H,3H)-pyrimidindion,
Fluouracil,
inhibits thymilidate synthetase,
Tolak,
2,4-Dioxo-5-fluoropryimidine,
5-fluorourasil,
Fluoro Uracil,
5-florouracil,
5-fluorouacil,
5-FU (TN),
5-Fluracil,
1upf,
5F-uracil,
U 8953,
1-fluoro-1h-pyrimidine-2,4-dione,
Adrucil (ICN),
IN1335,
Adrucil(Fluorouracil),
Adrucil (Fluorouracil),
Fluorouracil - Adrucil,
Fluorouracil [USAN:USP:INN:BAN:JAN],
Spectrum_000841,
ACMC-1ATRK,
Opera_ID_134,
AC1L1FTE,
Spectrum2_000076,
Spectrum3_000434,
Spectrum4_000557,
Spectrum5_000718,
WLN: T6MVMVJ EF,
Lopac-F-6627,
F0151,
UPCMLD-DP130,
EC 200-085-6,
F 6627,
AC1Q4N2X,
SCHEMBL3646,
5-fluorpyrimidin-2,4-diol,
Lopac0_000536,
BSPBio_002048,
KBioGR_001253,
KBioSS_001321,
KSC270K6T,
MLS002415705,
DivK1c_000054,
SPECTRUM1500305,
SPBio_000291,
5-fluoro-2,4-dioxo-pyrimidin,
5-fluoro-pyrimidine-2,4-diol,
GTPL4789,
DTXSID2020634,
UPCMLD-DP130:001,
CTK1H0569,
CTK8H4220,
Fluorouracil (JP17/USP/INN),
HMS500C16,
KBio1_000054,
KBio2_001321,
KBio2_003889,
KBio2_006457,
KBio3_001268,
5-Fluoro-2,3H)-pyrimidinedione,
2,4-Pyrimidinedione, 5-fluoro-,
NINDS_000054,
BCPP000428,
HMS1920O18,
HMS2090I04,
HMS2091F19,
HMS3259O03,
HMS3261L13,
HMS3654K22,
HMS3715H03,
Pharmakon1600-01500305,
5-Fluorouracil, analytical standard,
BCP02083,
KS-00000DY3,
2,3H)-Pyrimidinedione, 5-fluoro-,
Tox21_110150,
Tox21_202335,
Tox21_300112,
Tox21_500536,
ANW-31214,
BBL009635,
BDBM50340677,
CCG-39879,
CF0033,
DL-399,
LS-153,
NSC757036,
Ro-29757,
RW2456,
s1209,
SBB085751,
STK297802,
STL367375,
ZINC38212689,
AKOS000119162,
AKOS003237897,
AKOS008044307,
Tox21_110150_1,
AN-7240,
BCP9000239,
CS-0993,
DB00544,
KS-5129,
LP00536,
LS40596,
MCULE-6338086431,
NC00454,
NSC-757036,
RP19888,
IDI1_000054,
NCGC00015442-01,
NCGC00015442-03,
NCGC00015442-04,
NCGC00015442-05,
NCGC00015442-06,
NCGC00015442-07,
NCGC00015442-08,
NCGC00015442-09,
NCGC00015442-10,
NCGC00015442-11,
NCGC00015442-12,
NCGC00015442-15,
NCGC00015442-16,
NCGC00091349-01,
NCGC00091349-02,
NCGC00091349-03,
NCGC00091349-04,
NCGC00091349-05,
NCGC00091349-07,
NCGC00091349-08,
NCGC00254023-01,
NCGC00259884-01,
NCGC00261221-01,
4CA-0544,
5-Fluoro-2,4-(1H,3H)-pyrimidinedione,
AC-11201,
AJ-94651,
AK-46307,
BC227022,
CPD000038082,
HY-90006,
NCI60_001652,
SAM002264615,
SC-09038,
SRI-10792-04,
SRI-10792-05,
SRI-10792-06,
SRI-10792_07,
SRI-10792_08,
5-Fluoro-1H-pyrimidine-2,4-dione(5FU),
5-Fluorouracil, >=99% (HPLC), powder,
SBI-0050519.P004,
5-Fluoro-1H-pyrimidine-2,4-dione(5-FU),
AB1000177,
DB-051923,
DB-065735,
TL8006093,
5-Fluoro-1H-pyrimidine-2,4-dione (5-FU),
AM20100252,
EU-0100536,
FT-0082524,
FT-0601511,
FT-0707652,
ST45025877,
SW199617-3,
5-Fluoro-1H-pyrimidine-2,4-dione(5-FUra),
Fluorouracil, meets USP testing specifications,
51F218,
7375-EP2269989A1,
7375-EP2269994A1,
7375-EP2270008A1,
7375-EP2270018A1,
7375-EP2272827A1,
7375-EP2272832A1,
7375-EP2275102A1,
7375-EP2275412A1,
7375-EP2275413A1,
7375-EP2277876A1,
7375-EP2280012A2,
7375-EP2281563A1,
7375-EP2281815A1,
7375-EP2287156A1,
7375-EP2289892A1,
7375-EP2292233A2,
7375-EP2292614A1,
7375-EP2292615A1,
7375-EP2292617A1,
7375-EP2295416A2,
7375-EP2295426A1,
7375-EP2295427A1,
7375-EP2298748A2,
7375-EP2298768A1,
7375-EP2298772A1,
7375-EP2298780A1,
7375-EP2301928A1,
7375-EP2301933A1,
7375-EP2305219A1,
7375-EP2305243A1,
7375-EP2305640A2,
7375-EP2305642A2,
7375-EP2305671A1,
7375-EP2305689A1,
7375-EP2308833A2,
7375-EP2308839A1,
7375-EP2308855A1,
7375-EP2308861A1,
7375-EP2311807A1,
7375-EP2311808A1,
7375-EP2311825A1,
7375-EP2311827A1,
7375-EP2311829A1,
7375-EP2311840A1,
7375-EP2314590A1,
7375-EP2316459A1,
7375-EP2316831A1,
7375-EP2316834A1,
7375-EP2316974A1,
7375-EP2374454A1,
C07649,
D00584,
W-5036,
29507-EP2270008A1,
29507-EP2270505A1,
29507-EP2272827A1,
29507-EP2289892A1,
29507-EP2292234A1,
29507-EP2292617A1,
29507-EP2295426A1,
29507-EP2295427A1,
29507-EP2298305A1,
29507-EP2308861A1,
29507-EP2311842A2,
42164-EP2272827A1,
42164-EP2275420A1,
42164-EP2277565A2,
42164-EP2277566A2,
42164-EP2277567A1,
42164-EP2277568A2,
42164-EP2277569A2,
42164-EP2277570A2,
42164-EP2277876A1,
42164-EP2292280A1,
42164-EP2292614A1,
42164-EP2295412A1,
42164-EP2295413A1,
42164-EP2295416A2,
42164-EP2298748A2,
42164-EP2298764A1,
42164-EP2298765A1,
42164-EP2298778A1,
42164-EP2305642A2,
42164-EP2308833A2,
42164-EP2311808A1,
42164-EP2311829A1,
42164-EP2311840A1,
5-Fluorouracil, Vetec(TM) reagent grade, >=99%,
W-60379,
(5-fluorouracil)5-Fluoro-1H-pyrimidine-2,4-dione,
5-Fluoro-1H-pyrimidine-2,4-dione(5-fluoro uracil),
I07-0022,
SR-01000075881-1,
SR-01000075881-3,
SR-01000075881-5,
W-202929,
5-Fluoro-1H-pyrimidine-2,4-dione (5-Fluorouracil),
BRD-K24844714-001-02-1,
Z275128052,
5-Fluoro-1H-pyrimidine-2,4-dione(5-fluorouracil)(5-FU),
5-Fluorouracil, certified reference material, TraceCERT(R),
Fluorouracil, British Pharmacopoeia (BP) Reference Standard,
Fluorouracil, European Pharmacopoeia (EP) Reference Standard,
Fluorouracil, United States Pharmacopeia (USP) Reference Standard,
pyrimidine antimetabolite: inhibits nucleic acid replication; tetratogen,
2,4-Dihydroxy-5-fluoropyrimidine; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; 5-FU,
Fluorouracil, Pharmaceutical Secondary Standard; Certified Reference Material,
InChI=1/C4H3FN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9,
Fluoruracil,
Fluracedyl,
Flurodex,
Neofluor,
Onkofluor,
Ribofluor,
Haemato fu,
Haemato-fu,
tetratogen,
Flurablastin,
Masitinib,
Fluorouracil GRY,
Fluorouracil-GRY,
fluoruracil-,
5 FU Lederle,
5-FU Lederle,
Fluorouracile Dakota,
Fluoro Uracile ICN,
Fluoro-Uracile ICN,
5 FU medac,
5-FU medac,
5 HU Hexal,
5-HU Hexal,
Dakota, Fluorouracile,
5 Fluorouracil biosyn,
5-Fluorouracil-biosyn,
Efudex (TN),
Fluorouracil Mononitrate,
Fluorouracilo Ferrer Far,
Cantide + 5-FU,
Fluorouracil Teva Brand,
Fluorouracil Potassium Salt,
TS antisense + 5-FU,
Fluorouracil Monosodium Salt,
Gry Brand of Fluorouracil,
CSP Brand of Fluorouracil,
ICN Brand of Fluorouracil,
Uracil 5-fluoro-(8CI),
D05LEO,
D08EPN,
D0A7VK,
D0K7CG,
Dermik Brandof Fluorouracil,
Teva Brand of Fluorouracil,
Fluorouracil/5-Fluorouracil,
medac Brand of Fluorouracil,
Fluorouracil Monopotassium Salt,
Hexal Brand of Fluorouracil,
Roche Brand of Fluorouracil,
5-Fluorouracil, 99% 5g,
biosyn Brand of Fluorouracil,
Dakota Brand of Fluorouracil,
Ferrer Brand of Fluorouracil,
Haemato Brand of Fluorouracil,
Neocorp Brand of Fluorouracil,
Riemser Brand of Fluorouracil,
5-Fluoropyrimidine-2 4-diol,
Allergan Brand of Fluorouracil,
2 4-Dioxo-5-fluoropyrimidine,
5-Fluoro-2 4-pyrimidinedione,
Dermatech Brand of Fluorouracil,
Onkoworks Brand of Fluorouracil,
Fluorouracil (JP15/USP/INN),
ribosepharm Brand of Fluorouracil,
CID3385,
2 4-Dihydroxy-5-fluoropyrimidine,
C4-H3-F-N2-O2,
DRG-0161,
Fluorouracil [USAN:BAN:INN:JAN],
5-Fluoro Uracil 99% extra pure 1gm,
ACN-036606,
5-Fluoro-2 4(1H 3H)-pyrimidinedione,
2,4-Pyrimidinediol, 5-fluoro- (9CI),
5-Fluorouracil, 99% - 100G 100g,
2,4(1h,3h)-pirimidinadiona, 5-fluoro-,
A4071,
A7567,
A10042,
2(1H)-Pyrimidinone, 5-fluoro-4-hydroxy- (9CI),
4(3H)-Pyrimidinone, 5-fluoro-2-hydroxy- (9CI),
D005472,
191047-64-0,
191115-88-5,
790299-79-5,
DBL,
N-(4-methyl-3-(4-(pyridin-3-yl)thiazol-2-ylamino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide,
|
| Complexity | 199 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 130.018g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 9 |
| Hydrogen Bond Acceptor Count | 3 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 130.078g/mol |
| Monoisotopic Mass | 130.018g/mol |
| Rotatable Bond Count | 0 |
| Topological Polar Surface Area | 58.2A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | -0.9 |
| Symbol: | |
| Hazard Class | 6.1 |
| Hazard statements | H301-H351 |
| Packing Group | Ⅲ |
| Precautionary statements | P281-P301+P310 |
| UN Code | UN 2811 |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

